ED@crukcambridgecentre.org.uk
01223 763384
ED@crukcambridgecentre.org.uk
01223 763384
Eligibility: Applicants must be named Alliance Members and Group Leader/PI or equivalent at the University of Cambridge. The proposal must be within the scientific remit of the "Understanding Disease Progression for Early Detection" call and requires a co-applicant from another member centre. The deadline is 24th January. Click here for a list of ACED members at all Centres.
Funding period: Up to 36 months
Funding amount: From £200k to £1million
Submission deadlines:
* Intent to submit: 20th December 2021
* Completed applications: 24th January 2022
N.B. In a change to the previous process there is no longer an Expression of Interest stage and full Project submissions are invited by this deadline.
Eligibility: Applicants must be named Alliance Members and Group Leader/PI or equivalent at the University of Cambridge. The proposal must be within the scientific remit of the "Understanding Disease Progression for Early Detection" call and requires a co-applicant from another member centre. The deadline is 24th January. Click here for a list of ACED members at all Centres.
Funding period: Up to 12 months
Funding amount: Up to £200k
Submission deadlines:
* Intent to submit: 20th December 2021
* Completed applications: 24th January 2022
Eligibility: Interdisciplinary collaboration between Medicine and Artificial Intelligence / Machine Learning
Preliminary Internal submission deadline: 22nd February 2022
Submission deadline: 28th April 2022
Funding period: 3 years
Funding amount: £300,000
Restricted Call: Rosetrees Trust Interdisciplinary Prize 2022 to stimulate collaborative research between Medicine and Artificial Intelligence / Machine Learning
UK Institutions can submit a maximum of one application, so an internal selection process will be set up according to University’s Restricted Calls policy.
If you are interested in applying, please submit your application to the Research Strategy Office (researchstrategy@admin.cam.ac.uk) by 22nd February 2022.
Career level: Early career researcher; Mid-career researcher; Established independent researcher; scientists new to ED&D and/or cancer research; Non-clinical researcher; Clinician.
Submission deadline: 10 March 2022
Funding period: Up to 1 year
Funding amount: Up to £100k
Career level: Established independent researcher, Clinician or Non-clinical researcher
Outline application: 10th March 2022
Funding period: Five years
Funding amount: No value set
Career level: Established independent researcher; Non-clinical researcher; Clinician.
Submission deadline: 24 March 2022
Funding period: Up to 5 years
Funding amount: Up to £2.5million
The Milner Therapeutics Consortium is seeking proposals for academic-industry research collaborations that can transform pioneering science into therapies by developing better models of disease and uncovering novel and biologically informed targets.
The Milner Therapeutics Consortium second call for research proposals will close for applications on 30th March 2022.
Pharma partners in the Milner Therapeutics Consortium are working together with academics at the University, Babraham and Wellcome Sanger Institutes to better understand disease mechanisms and to discover and validate new therapeutic targets.